SPH report for August 2022

“Sopharma” AD (the Company) notifies that for August 2022 the Company recorded a decrease in sales of 12% compared to the same month of the previous year, incl. 6% increase in domestic sales and 21% decrease in export sales.
For the eight months since the beginning of the year the revenues from sales of products increase by 35%, incl. 37% increase of sales for the domestic market and 35% increase in export sales.